UBS Maintains Buy on Aptiv, Lowers Price Target to $80

Benzinga Newsdesk www.benzinga.com Neutral 61.3%

Neg 0% Neu 61.3% Pos 0%

UBS analyst Joseph Spak maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $97 to $80.

Comments

No comments yet. Be the first!